| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 工艺研究与开发(元) | 21,965,693.22 | 77,868,176.89 | 41,057,123.95 | 80,307,520.44 |
| 商业化生产(元) | 79,196,377.63 | 109,401,023.32 | 45,961,516.31 | 117,088,309.67 |
| 药物发现(元) | 158,235,327.69 | 293,209,093.03 | 137,895,540.55 | 274,726,371.37 |
| 药学研究(元) | - | - | 4,202,266.79 | - |
| 营业成本(元) | ||||
| 工艺研究与开发(元) | 20,367,456.24 | 54,363,713.94 | 23,458,390.43 | 44,807,815.18 |
| 商业化生产(元) | 76,451,558.83 | 92,086,218.57 | 34,001,187.97 | 87,478,945.98 |
| 药物发现(元) | 105,747,505.12 | 192,064,694.90 | 88,917,801.75 | 170,014,093.25 |
| 药学研究(元) | - | - | 2,959,561.19 | - |
| 毛利(元) | ||||
| 工艺研究与开发(元) | 1,598,236.98 | 23,504,462.95 | 17,598,733.52 | 35,499,705.26 |
| 商业化生产(元) | 2,744,818.80 | 17,314,804.75 | 11,960,328.34 | 29,609,363.69 |
| 药物发现(元) | 52,487,822.57 | 101,144,398.13 | 48,977,738.80 | 104,712,278.12 |
| 药学研究(元) | - | - | 1,242,705.60 | - |
| 毛利率(%) | ||||
| 工艺研究与开发(%) | 7.28 | 30.18 | 42.86 | 44.20 |
| 商业化生产(%) | 3.47 | 15.83 | 26.02 | 25.29 |
| 药物发现(%) | 33.17 | 34.50 | 35.52 | 38.12 |
| 药学研究(%) | - | - | 29.57 | - |
| 收入构成(%) | ||||
| 工艺研究与开发(%) | 8.47 | 16.21 | 17.92 | 17.01 |
| 商业化生产(%) | 30.53 | 22.77 | 20.06 | 24.80 |
| 药物发现(%) | 61.00 | 61.02 | 60.19 | 58.19 |
| 药学研究(%) | - | - | 1.83 | - |
| 毛利构成(%) | ||||
| 工艺研究与开发(%) | 2.81 | 16.56 | 22.06 | 20.90 |
| 商业化生产(%) | 4.83 | 12.20 | 14.99 | 17.44 |
| 药物发现(%) | 92.36 | 71.25 | 61.39 | 61.66 |
| 药学研究(%) | - | - | 1.56 | - |